Eye Exams Critical for Early Diagnosis
![A woman's bright blue eye up close](/images/Blog post images/Eye Exam.jpg)
"Various combination therapies have been explored in clinical trials. For example, targeting PDGF (Fovista) or the angiopoietin pathway. However, no major breakthrough has been reported. In fact, a phase III trial combining anti-VEGF and PDGF failed to demonstrate improved efficacy," said co-corresponding study author Dr. Yingbin Fu, associate professor and Sarah Campbell Blaffer Endowed Chair of Ophthalmology at Baylor.
San Diego Center for the Blind has a long history of helping people regain their independence. Please contact SDCB to learn more about our programs and services.
Combating drug resistance in age-related macular degeneration